RNS Number : 8952J

Eco Animal Health Group PLC

29 April 2022

29 April 2022

ECO Animal Health Group PLC


Date: 29 April 2022

 Name of applicant:                               ECO Animal Health Group plc 
 Name of scheme:                                  Executive Share Option Scheme 
                                                   and Unapproved Share Option Scheme 
 Number and class of securities                   1,500,000 ordinary shares of 
  originally listed and the date                   5 pence each on 20 July 2017 
  of admission: 
 Period of return:                   From:        1 May 2021      To:    29 April 2022 
                                    -----------  --------------  -----  ----------------- 
 Balance of unallotted securities 
  under scheme(s) from previous 
  return:                                         393,005 
 Plus: The amount by which the 
  block scheme(s) has been increased 
  since the date of the last return 
  (if any increase has been applied 
  for):                                           0 
 Less: Number of securities issued/allotted 
  under scheme(s) during period:                  17,500 
 Equals: Balance under scheme(s) 
  not yet issued/allotted at end 
  of period:                                      375,505 

For further information, please contact:

   ECO Animal Health Group plc 
   David Hallas (CEO) 
   Christopher Wilks (CFO)                     020 8447 8899 
 IFC Advisory 
  Graham Herring 
  Zach Cohen                                  020 3934 6630 
 Singer Capital Markets (Nominated Adviser 
  & Joint Broker) 
  Mark Taylor 
  George Tzimas                               020 7496 3000 
 Investec (Joint Broker) 
  Gary Clarence 
  Alex Penney                                 020 7597 5970 
  Carlo Spingardi 
  Peel Hunt LLP (Joint Broker) 
  Dr Christopher Golden 
  James Steel                                  020 7418 8900 
 Equity Developments 
  Hannah Crowe 
  Matt Evans            020 7065 2692 

About ECO Animal Health

ECO Animal Health Group plc researches, develops and commercialises products for livestock. Our business strategy is to generate shareholder value by achieving the maximum sales potential from the existing product portfolio whilst investing in Research and Development ("R&D") for new products, particularly vaccines, and seeking to in-license new products.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.



(END) Dow Jones Newswires

April 29, 2022 06:47 ET (10:47 GMT)

Eco Animal Health (LSE:EAH)
Gráfica de Acción Histórica
De May 2022 a Jun 2022 Haga Click aquí para más Gráficas Eco Animal Health.
Eco Animal Health (LSE:EAH)
Gráfica de Acción Histórica
De Jun 2021 a Jun 2022 Haga Click aquí para más Gráficas Eco Animal Health.